Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet function. - Parra-Izquierdo, Iván; Melrose, Alexander R.; Pang, Jiaqing; Lakshmanan, Hari Hara Sudhan; Reitsma, Stéphanie E.; Vavilapalli, Sai Hitesh; Larson, Mark K.; Shatzel, Joseph J.; McCarty, Owen J. T.; Aslan, Joseph E. (Platelets, 2022)